Angiotensin Receptor Blockers (ARBs) Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
697 | Date :
Jan, 2023 | Pages :
168 | Region : Global |
Publisher : Ri research
Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The Global Angiotensin Receptor Blockers (ARBs) Market was valued at xxx million USD with a CAGR xx% from 2018-2022. Subsequently, it will touch xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Angiotensin Receptor Blockers (ARBs) Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan In Market segmentation by applications :
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Angiotensin Receptor Blockers (ARBs) Market for the forecast period 2023-2030?
• What are the driving forces in the Angiotensin Receptor Blockers (ARBs) Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Angiotensin Receptor Blockers (ARBs) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
Executive Summary
1 Angiotensin Receptor Blockers (ARBs) Market Overview
1.1 Product Overview and Scope of Angiotensin Receptor Blockers (ARBs)
1.2 Angiotensin Receptor Blockers (ARBs) Segment by Type
1.2.1 Global Angiotensin Receptor Blockers (ARBs) Production Growth Rate Comparison by Type (2015-2030)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Angiotensin Receptor Blockers (ARBs) Segment by Application
1.3.1 Angiotensin Receptor Blockers (ARBs) Consumption Comparison by Application (2015-2030)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global Angiotensin Receptor Blockers (ARBs) Market by Region
1.4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size Region
1.4.2 North America Status and Prospect (2015-2030)
1.4.3 Europe Status and Prospect (2015-2030)
1.4.4 China Status and Prospect (2015-2030)
1.4.5 Japan Status and Prospect (2015-2030)
1.5 Global Angiotensin Receptor Blockers (ARBs) Market Size
1.5.1 Global Angiotensin Receptor Blockers (ARBs) Revenue (2015-2030)
1.5.2 Global Angiotensin Receptor Blockers (ARBs) Production (2015-2030)
2 Global Angiotensin Receptor Blockers (ARBs) Market Competition by Manufacturers
2.1 Global Angiotensin Receptor Blockers (ARBs) Production Market Share by Manufacturers (2018 - 2022)
2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers (2018 - 2022)
2.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Manufacturers (2018 - 2022)
2.4 Manufacturers Angiotensin Receptor Blockers (ARBs) Production Sites, Area Served, Product Types
2.5 Angiotensin Receptor Blockers (ARBs) Market Competitive Situation and Trends
2.5.1 Angiotensin Receptor Blockers (ARBs) Market Concentration Rate
2.5.2 Angiotensin Receptor Blockers (ARBs) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Angiotensin Receptor Blockers (ARBs) Production Market Share by Regions
3.1 Global Angiotensin Receptor Blockers (ARBs) Production Market Share by Regions
3.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Regions (2018 - 2022)
3.3 Global Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
3.4 North America Angiotensin Receptor Blockers (ARBs) Production
3.4.1 North America Angiotensin Receptor Blockers (ARBs) Production Growth Rate (2018 - 2022)
3.4.2 North America Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
3.5 Europe Angiotensin Receptor Blockers (ARBs) Production
3.5.1 Europe Angiotensin Receptor Blockers (ARBs) Production Growth Rate (2018 - 2022)
3.5.2 Europe Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
3.6 China Angiotensin Receptor Blockers (ARBs) Production (2018 - 2022)
3.6.1 China Angiotensin Receptor Blockers (ARBs) Production Growth Rate (2018 - 2022)
3.6.2 China Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
3.7 Japan Angiotensin Receptor Blockers (ARBs) Production (2018 - 2022)
3.7.1 Japan Angiotensin Receptor Blockers (ARBs) Production Growth Rate (2018 - 2022)
3.7.2 Japan Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
4 Global Angiotensin Receptor Blockers (ARBs) Consumption by Regions
4.1 Global Angiotensin Receptor Blockers (ARBs) Consumption by Regions
4.2 North America Angiotensin Receptor Blockers (ARBs) Consumption (2018 - 2022)
4.3 Europe Angiotensin Receptor Blockers (ARBs) Consumption (2018 - 2022)
4.4 China Angiotensin Receptor Blockers (ARBs) Consumption (2018 - 2022)
4.5 Japan Angiotensin Receptor Blockers (ARBs) Consumption (2018 - 2022)
5 Global Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price Trend by Type
5.1 Global Angiotensin Receptor Blockers (ARBs) Production Market Share by Type (2018 - 2022)
5.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2018 - 2022)
5.3 Global Angiotensin Receptor Blockers (ARBs) Price by Type (2018 - 2022)
5.4 Global Angiotensin Receptor Blockers (ARBs) Production Growth by Type (2018 - 2022)
6 Global Angiotensin Receptor Blockers (ARBs) Market Analysis by Applications
6.1 Global Angiotensin Receptor Blockers (ARBs) Consumption Market Share by Application (2018 - 2022)
6.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Growth Rate by Application (2018 - 2022)
7 Company Profiles and Key Figures in Angiotensin Receptor Blockers (ARBs) Business
7.1 Pfizer
7.1.1 Pfizer Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.1.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.1.4 Main Business and Markets Served
7.2 Novartis
7.2.1 Novartis Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.2.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.2.4 Main Business and Markets Served
7.3 Merck
7.3.1 Merck Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.3.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.3.3 Merck Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.3.4 Main Business and Markets Served
7.4 Astra Zeneca
7.4.1 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.4.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.4.4 Main Business and Markets Served
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.5.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.5.4 Main Business and Markets Served
7.6 Eli Lilly
7.6.1 Eli Lilly Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.6.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.6.4 Main Business and Markets Served
7.7 Sanofi
7.7.1 Sanofi Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.7.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.7.3 Sanofi Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.7.4 Main Business and Markets Served
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.8.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.8.4 Main Business and Markets Served
7.9 Bayer
7.9.1 Bayer Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.9.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.9.4 Main Business and Markets Served
7.10 GSK
7.10.1 GSK Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
7.10.2 Angiotensin Receptor Blockers (ARBs) Product Introduction, Application and Specification
7.10.3 GSK Angiotensin Receptor Blockers (ARBs) Production, Revenue, Price and Gross Margin (2018 - 2022)
7.10.4 Main Business and Markets Served
7.11 Teva Pharmaceutical
8 Angiotensin Receptor Blockers (ARBs) Manufacturing Cost Analysis
8.1 Angiotensin Receptor Blockers (ARBs) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
8.4 Angiotensin Receptor Blockers (ARBs) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Angiotensin Receptor Blockers (ARBs) Distributors List
9.3 Angiotensin Receptor Blockers (ARBs) Customers
11 Global Angiotensin Receptor Blockers (ARBs) Market Forecast
11.1 Global Angiotensin Receptor Blockers (ARBs) Production, Revenue Forecast
11.1.1 Global Angiotensin Receptor Blockers (ARBs) Production Growth Rate Forecast (2020-2030)
11.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue and Growth Rate Forecast (2020-2030)
11.1.3 Global Angiotensin Receptor Blockers (ARBs) Price and Trend Forecast (2020-2030)
11.2 Global Angiotensin Receptor Blockers (ARBs) Production Forecast by Regions (2020-2030)
11.2.1 North America Angiotensin Receptor Blockers (ARBs) Production, Revenue Forecast (2020-2030)
11.2.2 Europe Angiotensin Receptor Blockers (ARBs) Production, Revenue Forecast (2020-2030)
11.2.3 China Angiotensin Receptor Blockers (ARBs) Production, Revenue Forecast (2020-2030)
11.2.4 Japan Angiotensin Receptor Blockers (ARBs) Production, Revenue Forecast (2020-2030)
11.3 Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast by Regions (2020-2030)
11.3.1 North America Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2020-2030)
11.3.2 Europe Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2020-2030)
11.3.3 China Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2020-2030)
11.3.4 Japan Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2020-2030)
11.4 Global Angiotensin Receptor Blockers (ARBs) Production, Revenue and Price Forecast by Type (2020-2030)
11.5 Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast by Application (2020-2030)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
